Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa

View ORCID ProfileChristian L. Althaus, Stephanie Baggio, Martina L. Reichmuth, Emma B. Hodcroft, Julien Riou, Richard A. Neher, Frédérique Jacquerioz, Hervé Spechbach, Julien Salamun, Pauline Vetter, Carolyn Williamson, Nei-yuan Hsiao, Wolfgang Preiser, Mary-Ann Davies, Richard J. Lessells, Tulio de Olivera, Laurent Kaiser, Isabella Eckerle
doi: https://doi.org/10.1101/2021.06.10.21258468
Christian L. Althaus
aInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian L. Althaus
  • For correspondence: christian.althaus@ispm.unibe.ch
Stephanie Baggio
bDivision of Prison Health, Geneva University Hospitals, Geneva, Switzerland
cOffice of Corrections, Department of Justice and Home Affairs of the Canton of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina L. Reichmuth
aInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
dGraduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma B. Hodcroft
aInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
eSwiss Institute of Bioinformatics, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien Riou
aInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Neher
eSwiss Institute of Bioinformatics, Basel, Switzerland
fBiozentrum, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédérique Jacquerioz
gGeneva Center for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
hDivision of Tropical and Humanitarian Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
iPrimary Care Division, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hervé Spechbach
iPrimary Care Division, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien Salamun
iPrimary Care Division, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pauline Vetter
gGeneva Center for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
jLaboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Williamson
kDivision of Medical Virology, Wellcome Centre for Infectious Diseases Research in Africa & the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
lDivision of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
mCentre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nei-yuan Hsiao
kDivision of Medical Virology, Wellcome Centre for Infectious Diseases Research in Africa & the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
lDivision of Medical Virology at NHLS Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Preiser
nDivision of Medical Virology, University of Stellenbosch / National Health Laboratory Service Tygerberg, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary-Ann Davies
oCentre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa
pWestern Cape Government: Health, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Lessells
mCentre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
qKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Department of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tulio de Olivera
mCentre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
qKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Department of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
rDepartment of Global Health, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Kaiser
gGeneva Center for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
jLaboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabella Eckerle
gGeneva Center for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Several SARS-CoV-2 variants of concern (VOC) are spreading rapidly in different regions of the world. The underlying mechanisms behind their transmission advantage remain unclear. We measured viral load in 950 individuals and found that infections with variant Alpha exhibit a higher viral load and longer viral shedding compared to non-VOC. We then used a transmission model to analyze the spread of variant Alpha in Geneva, Switzerland, and variant Beta in South Africa. We estimated that Alpha is either associated with a 37% (95% compatibility interval, CI: 25–63%) increase in transmissibility or a 51% (95% CI: 32–80%) increase of the infectious duration, or a combination of the two mechanisms. Assuming 50% immune evasion for Beta, we estimated a 23% (95% CI: 10–37%) increase in transmissibility or a 38% (95% CI: 15–78%) increase of the infectious duration for this variant. Beta is expected to outgrow Alpha in regions where the level of naturally acquired immunity from previously circulating variants exceeds 20% to 40%. Close monitoring of Alpha and Beta in regions with different levels of immunity will help to anticipate the global spread of these and future variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

CA received funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (No 101003688). CA, RN and EH received funding from the Swiss National Science Foundation (grant 196046). IE received funding from the Swiss National Foundation (grant 196644 and 196383) and the Private HUG Foundation by the Pictet Charitable Foundation. NGS-SA was supported by the Strategic Health Innovation Partnerships Unit of the South African Medical Research Council, with funds received from the South African Department of Science and Innovation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study (information on Ct value and days post onset of symptoms of SARS-CoV-2 positive individuals) was approved by the HUG institutional ethics board (no. 2020-00813).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data and R code files are available on GitHub: https://github.com/calthaus/sarscov2-variants.

https://github.com/calthaus/sarscov2-variants

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa
Christian L. Althaus, Stephanie Baggio, Martina L. Reichmuth, Emma B. Hodcroft, Julien Riou, Richard A. Neher, Frédérique Jacquerioz, Hervé Spechbach, Julien Salamun, Pauline Vetter, Carolyn Williamson, Nei-yuan Hsiao, Wolfgang Preiser, Mary-Ann Davies, Richard J. Lessells, Tulio de Olivera, Laurent Kaiser, Isabella Eckerle
medRxiv 2021.06.10.21258468; doi: https://doi.org/10.1101/2021.06.10.21258468
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa
Christian L. Althaus, Stephanie Baggio, Martina L. Reichmuth, Emma B. Hodcroft, Julien Riou, Richard A. Neher, Frédérique Jacquerioz, Hervé Spechbach, Julien Salamun, Pauline Vetter, Carolyn Williamson, Nei-yuan Hsiao, Wolfgang Preiser, Mary-Ann Davies, Richard J. Lessells, Tulio de Olivera, Laurent Kaiser, Isabella Eckerle
medRxiv 2021.06.10.21258468; doi: https://doi.org/10.1101/2021.06.10.21258468

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10299)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1768)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)